Ivermectin and Hydroxychloroquine for Chemo-Prophylaxis of COVID-19: A Questionnaire Survey of Perception and Prescribing Practice of Physicians vis-a-vis Outcomes
CONCLUSION: The HCPs found IVR to have a greater risk reduction than with HCQ; while the combination showed the greatest reduction and lack of CP use was associated with a high risk of SARS-CoV-2 infection.PMID:34781604
Source: Journal of the Association of Physicians of India - Category: General Medicine Authors: Shambo Samrat Samajdar Shatavisa Mukherjee Tanuka Mondal Jyotirmoy Paul Santanu K Tripathi Ajay Chakrbarty Bibhuti Saha Debasish Bhattacharrya Rohan Tripathi Source Type: research
More News: COVID-19 | General Medicine | Hydroxychloroquine | India Health | Pandemics | SARS | Study